Charles W. Newhall III
Director · SUPERNUS PHARMACEUTICALS, INC.
- 2024
- Feb 25, 2026
- 8
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Charles W. Newhall III files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Padmanabh P. Bhatt - $5.39M in SUPN purchases and sales in the last 12 months
- Jack A. Khattar - $1.76M in SUPN purchases and sales in the last 12 months
- Georges Gemayel - $1.00M in SUPN purchases and sales in the last 12 months
- William Todd Horich - $484K in SUPN purchases and sales in the last 12 months
- Frederick M. Hudson - $272K in SUPN purchases and sales in the last 12 months
- Bethany Sensenig - $228K in SUPN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Charles W. Newhall III?
Charles W. Newhall III is a corporate insider, tracked as Director of SUPERNUS PHARMACEUTICALS, INC. (SUPN). InsiderAlpha holds 8 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Charles W. Newhall III last file a Form 4?
The most recent primary Form 4 on record is dated 25 February 2026, one of 8 filings going back to 2024.
Has Charles W. Newhall III been buying or selling stock?
Recorded transactions: 0 open-market purchases and 6 open-market sales ($1.93M) across all tracked filings.
